Physician profile
John D Hansill
NPI 1770892184
$6,389.49
in general payments reported to CMS, 2019-2025
54 companies · $475 in 2025
The $475 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $229 · 2021: $1,261 · 2022: $1,723 · 2023: $978 · 2024: $783 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,141 · Education: $69.99 · Gift: $25.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,140.86 |
| Education | $69.99 |
| Gift | $25.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $797.73 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $702.06 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $516.26 | 2019-2024 | |
| Karl Storz Endoscopy-America | $502.64 | 2021-2024 | Image 1 S, Image1 S Connect, Tele Pack |
| Mayne Pharma Commercial LLC | $385.94 | 2021-2025 | |
| Ethicon US, LLC | $201.68 | 2021-2024 | Surgiflo Hemostatic Matrix, Vistaseal, Ethicon |
| Coopersurgical, INC. | $177.02 | 2019-2025 | Paragard T 380a, Summit Doppler, Paragard T 380a |
| Renovia INC | $173.81 | 2021 | |
| Hologic Sales and Service, LLC | $157.71 | 2019-2025 | Thinprep 2000 Processor, Aptima, Omni Hysteroscope |
| Therapeuticsmd, INC. | $139.55 | 2019-2021 | |
| Acera Surgical, INC. | $133.74 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $132.82 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.84 | 2019-2025 | |
| Pfizer INC. | $128.13 | 2019-2025 | |
| Boston Scientific Corporation | $124.39 | 2019-2025 | Axonics |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $115.78 | 2020-2023 | Slynd |
| Amgen INC. | $112.36 | 2019-2024 | Evenity, Prolia |
| Evofem Biosciences, INC. | $110.27 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $106.27 | 2019-2023 | Andexxa |
| Allergan, INC. | $102.97 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $95.81 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $93.33 | 2021 | |
| Thd America, INC. | $91.10 | 2019 | |
| Exact Sciences Corporation | $90.25 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $89.44 | 2021-2025 | Nexplanon, Jada System |
| Femselect INC. | $82.51 | 2024 | Enplace |
| Mimedx Group, INC. | $79.32 | 2024 | |
| Coloplast Corp | $69.94 | 2019-2025 | |
| Radius Health, INC. | $56.60 | 2019 | |
| Mylan Pharmaceuticals INC. | $56.28 | 2020-2021 | |
| Avion Pharmaceuticals | $51.77 | 2020-2022 | |
| Meditrina | $48.24 | 2021-2025 | |
| Baxter Healthcare | $46.33 | 2023 | Tisseel |
| Medtronic, INC. | $42.77 | 2021-2023 | Interstim |
| Agile Therapeutics, INC. | $41.84 | 2021 | |
| Sumitomo Pharma America, INC. | $35.87 | 2023-2025 | Myfembree, Gemtesa |
| Duchesnay USA Incorporated | $34.98 | 2019 | |
| Channel Medsystems, INC. | $31.36 | 2023 | |
| Myovant Sciences INC. | $28.17 | 2021-2022 | |
| Sanara Medtech INC. | $27.17 | 2022 | |
| Conmed Corporation | $26.86 | 2024 | Airseal |
| Covidien LP | $25.83 | 2019 | |
| Caldera Medical, INC | $25.49 | 2023 | Desara |
| Biogen, INC. | $24.60 | 2025 | Zurzuvae |
| Vertical Pharmaceuticals, LLC | $22.94 | 2019 | |
| Ascend Therapeutics US, LLC | $17.42 | 2024 | |
| Merck Sharp & Dohme LLC | $17.07 | 2019 | |
| Aspira Women'S Health INC | $16.71 | 2020 | |
| Currax Pharmaceuticals LLC | $16.08 | 2024 | Contrave |
| Portola Pharmaceuticals, LLC | $14.51 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.06 | 2019 | |
| Minerva Surgical, INC | $12.51 | 2021 | |
| Medicem INC. | $12.36 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hansill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.